Lomitapide Pregnancy and Breastfeeding Warnings
Lomitapide is also known as: Juxtapid
Lomitapide Pregnancy Warnings
Lomitapide may cause fetal harm when administered to a pregnant woman. Animal studies at 2- to 5-times the human dose resulted in umbilical hernia, gastroschisis, imperforate anus, alterations in heart shape and size, kinking and skeletal malformations of the tail, delayed ossification of cranial, vertebral and pelvic bones, medially rotated or short limbs, absent or fused digits on paws, cleft palate, open eye lids, and lowset ears. Females of reproductive potential should have a negative pregnancy test before starting lomitapide. If oral contraceptives are used, the maximum recommended dosage is 30 mg daily.
FDA pregnancy category: X Use of lomitapide is contraindicated. Comments: Encourage use of adequate methods of contraception. If lomitapide is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to a fetus.
Lomitapide Breastfeeding Warnings
Lomitapide has been shown to have tumorigenicity potential in mouse studies.
A decision should be made to discontinue breast-feeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Yes The effects in the nursing infant are unknown.
- lomitapide Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.